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Although the mushrooms or macroscopic fungi were a significant part of 
several cultures through the ages, they were always considered mystical, 
mostly unknown and hard to define. This tradition lives with us even now, 
as fungi have been chosen not to be a part of the kingdom of Plants or 
Animals, however, earned its own kingdom with vaguely defined borders. 
As a part of this group, the mushrooms are widely described as well. 
According to the definition from Chang and Miles, these organisms are 
mentioned as “a macrofungi with a distinctive fruiting body, which can be 
hypogeous or epigeous, large enough to be seen with the naked eye and to be 
picked by hand”. 
Despite (or sometimes because of) this mystical reputation, these 
beings have been used since the early ages of humanity. With regards to their 
application, probably the most ancient and simplest ones were in terms of 
nourishment, due to their easy to collect nature, unique taste and high 
nutritional value. In addition to the benefits detailed above, the mushrooms 
also tend to contain components that effect the homeostasis in other ways. 
Correspondingly, the poisonous mushrooms are the most well-known 
example of that, but some species also contain compounds with psychoactive 
and beneficial pharmacological effects.  
Even the Iceman, a more than 5000 years old mummy found in the 
Alps collected mushrooms for spiritual-medical purposes, furthermore 
numerous reports of mushrooms (especially polypores) with beneficial 
effects are known from this region in the later periods as well. For instance, 
Laetiporus sulphureus, a polypore native to the area was commonly used for 
the treatment of pyretic diseases, coughs, gastric cancer, rheumatism, insect 
repellent for mosquitoes and midges, meanwhile the young fruiting body was 
also considered a delicacy, earning the name chicken polypore. Another great 
illustration is Fomes fomentarius that was used for cauterization since the 
 
age of Hippocrates and applied as a styptic in Austria up to the 19th century. 
Interestingly, the application of this species was not limited to external use, 
since this polypore was also believed as a remedy against dysmenorrhoea, 
haemorrhoids, bladder diseases, pain, and gastric carcinomas. Additionally, 
a third polypore, Piptoporus betulinus also had a role in the history of the 
European medicinal mushrooms. This edible species was mostly prepared as 
a tea for enhancing the immune system and reducing fatigue. 
Although these results are considerable and the role of polypores in 
Central European ethnomedicine is notable, further investigations are 
needed, as this field is far from complete description in terms of both 
composition and pharmacological effects of the mushrooms. This was the 
main motivation behind the decision for our workgroup to explore the 
bioactive metabolites of the native Hungarian mushrooms. Preliminary 
studies performed by our research group unequivocally demonstrated that 
polypore species represent an untapped potential in terms of antiproliferative, 
antioxidant and antimicrobial effects. Based on our preliminary studies and 
literature search we selected 3 polypores, Meripilus giganteus, Porodaedalea 
chrysoloma and Fuscoporia torulosa to be the topic of my research and this 
thesis. 
AIMS OF THE STUDY 
In 2012 the research project was started at the Department of Pharmacognosy 
(University of Szeged) in collaboration with the Department of 
Pharmacodynamics and Biopharmacy and the Department of Medical 
Microbiology and Immunology with the aim of investigating the bioactive 
compounds of Hungarian native mushrooms. The primary goal was to 
identify the most promising species in terms of pharmacological properties 
and then isolate the active fungal metabolites responsible for the observed 
biological activity. A screening study performed by Bernadett Kovács et al. 
 
preceding this present work revealed that some important Central European 
Phellinus species (including Porodaedalea chrysoloma and Fuscoporia 
torulosa) possess significant antioxidant properties, worth for further 
investigation and compound isolation. These species, complemented with 
Meripilus giganteus formed the basis of my work.  
To achieve our goal, the following task were performed: 
 Review the available literature data and screening results for the 
chosen species, with emphasis on the chemical profile and known 
pharmacological properties. 
 Grind and extract the collected mushroom samples with methanol. 
 Separate and isolate the pure components utilizing solvent-solvent 
partition and various chromatographic methods. 
 Elucidate the structure of isolated constituents using NMR and MS 
methods (collaborating with Richter Gedeon Plc., Hungary). 
Provide characteristic NMR spectroscopic data for the new 
compounds and supplement the missing NMR data for the known 
ones. 
 Evaluate the pharmacological potential of the isolated compounds 
(at the Department of Pharmacognosy in collaboration with the 
Department of Medical Microbiology and Immunobiology). 
MATERIALS AND METHODS 
For preparative mycochemical work fresh fruiting bodies of M. giganteus 
(12 kg) were collected on Mecsek and Visegrád Mountains between 2014 
and 2016. Dry mushroom materials of P. chrysoloma (360 g) were collected 
in Sweden and in the Czech Republic, while samples of F. torulosa (1425 g) 
were found on Gerecse Mountain and in the Botanical Garden of Buda, 
Hungary. 
 
In the initial step of the preparative work, the dried or raw 
mushroom materials were percolated with an amphipolar solvent (MeOH). 
The concentrated extracts were diluted with 50% methanol and liquid–liquid 
extraction was employed, which resulted in n-hexane, chloroform and ethyl-
acetate phases. 
The investigated extracts were fractionated with different type of 
multistep chromatographic procedures, like thin-layer chromatography 
(TLC), flash column chromatography (FCC) and high-performance liquid 
chromatography (HPLC). Normal- or reversed-phase SiO2 were applied as 
stationary phases. 
The structures of the obtained compounds were characterized by 
spectroscopic methods (NMR and MS).  
The in vitro antioxidant activity was investigated by DPPH and 
ORAC assays. The studies were carried out on a 96-well microplate using 
FLUOStar Optima plate reader. 
The cytotoxic properties of the isolated compounds were 
determined by means of MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide] assay on U937 human lung (lymphoblast), 
human colonic adenocarcinoma and embryonic lung fibroblast cells. The 
interaction of the isolated compounds from Fuscoporia torulosa with the 
chemotherapeutic drug doxorubicin was investigated as well on Colo 320 
(colon adenocarcinoma) cell line, while P-gp efflux modulation effect was 
assessed via Rhodamine 123 accumulation assay on the same type of cells. 
Antimicrobial effects were measured against Escherichia coli, 
Salmonella enterica, Staphylococcus aureus and the methicillin and 
ofloxacin resistant S. aureus. The minimal inhibitory concentration (MICs) 
was determined by inspection with naked eye. 
 
 
RESULTS AND DISCUSSION 
Isolation of the compounds of M. giganteus 
Both n-hexane and chloroform fraction of M. giganteus yielded pure 
compounds. Flash chromatography was applied in both cases supported by 
high performance liquid chromatography (n-hexane fraction) and 
preparative thin layer chromatography (chloroform fraction) (Figure 1). This 
purification process led to the isolation of 9 compounds. 
 
Figure 1. Isolation of compounds from M. giganteus 
Isolation of the compounds of P. chrysoloma 
In the case of P. chrysoloma the n-hexane phase was fractionated, and the 
combined fractions were further analyzed using repeated FCC (Figure 2). 
Thanks to chromatographic separations five compounds were isolated. 
 
Figure 2. Isolation of compounds from P. chrysoloma 
 
Isolation of the compounds of F. torulosa 
In case of F. torulosa the n-hexane, chloroform and ethyl-acetate fractions 
led to the isolation of pure compounds (Figure 3). By applying both FCC 
and HPLC, the n-hexane and chloroform fractions yielded 3-3 components, 
while the ethyl-acetate fraction 2 compounds. 
 
Figure 3. Isolation of compounds from F. torulosa 
Compounds from Meripilus giganteus 
The separation and the structure determination have enabled the 
identification of 9 compounds. Three of them (compounds 1-3) belong to the 
group of cerebrosides; two of them, mericeramides A (1) and B (2), are new 
natural products, while compound 3 is the known cerebroside B. To the best 
of our knowledge mericeramide B (2) is the first natural halogenated 
cerebroside identified.  
Ergosterol (4) and 3β-hydroxyergosta-7,22-diene (5) were 
identified based on the comparison of chromatographic and spectral data 
with the available standards. Cerevisterol (6), 3β-hydroxyergosta-
6,8(14),22-triene (7), 3β-O-glucopyranosyl-5,8-epidioxyergosta-6,22-diene 
(8) and (11E,13E)-9,10-dihydroxy-11,13-octadecadienoic acid (9) were 
 
characterized on the basis of HRMS, MS-MS and standard 1D and 2D NMR 
data compared to those reported in the literature. 
 
 
Compounds from Porodaedalea chrysoloma 
After processing the Porodaedalea chrysoloma sample, 5 compounds were 
isolated, out of which one (10) was found for the first time as a natural 
product. 
Compound 10 was isolated as a white, amorphous solid with the 
molecular formula of C12H12O5. According to the 1H NMR spectrum signals 
of mutually coupled protons and the 1H-1H COSY spectrum, the presence of 
p-disubstituted benzene ring and a trans-double bond was suspected in the 
molecule. Based on the above mentioned and further results gained from 
JMOD, HSQC, COSY, HMBC and NOESY spectra, the structure was 
established as methyl (E)-3-(4-methoxycarbonylphenoxy)-acrylate. 
Compound 11 was manifested as white amorphous granulates with 
the composition of C12H14O5. The 1H NMR spectrum was shown high level 
 
of similarity with compound 10, however, lacking the protons attributed to 
the E-double bond, yet showing the signs of two new methylenes. According 
to these data an exchange was suggested from the acrylate part to a methyl-
propionate, compared to compound 10. This afforded the structure of methyl 
3-(4-methoxycarbonylphenoxy)-propionate, a new compound from natural 
source. 
Ergone (12) was characterized by a comparison of the achieved 
NMR and the available literature data. Ergosterol (4) and 3β-hydroxyergosta-
7,22-diene (5) were identified by matching their chromatographic and 
spectroscopic data to an authentic sample isolated previously. 
 
 
Compounds from Fuscoporia torulosa 
Processing the sample of Fuscoporia torulosa allowed the isolation of 8 
components. Structure determination identified compound 13 as a novel 
triterpene, named fuscoporic acid, while 15 proved to be a previously 
undescribed Z isomer of inoscavin. 
Based on 1H and 13C NMR spectra 13 is based on degraded 
lanosterol skeleton similarly as natalic acid (19), which was also isolated 
from F. torulosa. 
Compounds 14 and 15 represent a mixture of inoscavin A and its Z 
isomer in a ca. 5 to 3 molar ratio. To the best of our knowledge the Z isomer 
has not yet been reported in the literature before. 
According to spectral analysis 16 and 17 represent an equimolar 
mixture of 3,4-dihydroxy-benzaldehyde and osmundacetone. The remaining 
 
constituents are triterpenes, namely senexdiolic acid (18), and ergosta-7,22-
diene-3-one (20). 
   
13    14, 15 
       
16  17   18 
 
19   20 
Pharmacological activities of isolated compounds 
Antioxidant activity of the compounds from Meripilus giganteus 
All 9 of the isolated compounds (1-9) from Meripilus giganteus were 
examined in terms of antioxidant activity with ORAC assay. With regard to 
the results, mericeramide B (2), 3β-hydroxyergosta-7,22-diene (5), and 
(11E,13E)-9,10-dihydroxy-11,13-octadecadienoic acid (9) showed 





Table 1. Antioxidant activity of the compounds from Meripilus giganteus 










Ascorbic acid 6.96±0.57 
 
Antioxidant activity of the compounds from Porodaedalea chrysoloma 
The antioxidant activity of the isolated compounds was analysed by ORAC 
assay. The obtained results showed notable antioxidant properties, 
furthermore, these values were comparable to that of ascorbic acid used as a 
reference material. The measurement showed that 2 out of 5 components 
possess notable antioxidant activity: the methyl (E)-3-(4-
methoxycarbonylphenoxy)-acrylate (10) and 3β-hydroxyergosta-7,22-diene 
(5). 
Table 2. Antioxidant activity of the compounds from Porodaedalea chrysoloma 






Ascorbic acid 16.47±0.01 
 
Antioxidant activity of the compounds from Fuscoporia torulosa  
Compound 14-17 isolated from F. torulosa were examined for their potential 
antioxidant effects using DPPH and ORAC assay. Both measurements 
concluded similar findings: all the tested compounds showed notable 
antioxidant effect in the order of compounds 16 + 17 < 14 + 15, while 
 
compounds 14 + 15 possessed the most potent antioxidant capacity among 
all the tested compounds discussed in this thesis. 
Table 3. Antioxidant activity of the compounds from Fuscoporia torulosa 
Compounds DPPH IC50 (µg/mL) 
14 + 15 0.72±0.05 
16 + 17 0.25±0.01 
 ORAC Antioxidant Activity (mmol TE/g) 
14 + 15 2.70±0.03 
16 + 17 12.20±0.92 
  
Cytotoxic activity of the compounds from Fuscoporia torulosa 
Compounds 13 and 18-20 were screened for cytotoxic effects on 
adenocarcinoma cell lines. Doxorubicin-sensitive Colo 205 and the 
anticancer agent resistant Colo 320 were applied, together with MRC-5 
human embryonic lung fibroblast cell lines.  Compounds 13, 18 and 19 were 
ineffective, however, the determined IC50 for ergosta-7,22-diene-3-one (20) 
was comparable to those determined for doxorubicin used as reference 
substance. Furthermore ergosta-7,22-diene-3-on (20) was more effective as 
the reference agent on MRC-5 cell lines. 
Table 4. Cytotoxic activity of the compounds from Fuscoporia torulosa (IC50 µM) 
Compounds Colo205  Colo320  MRC-5  
20 11.65±1.67 8.43±1.1 7.92±1.42 
Doxo 2.46±0.26 7.44±0.2 >20 
After these results, a checkboard combination assay was also 
performed, looking for potential effect enhancement in case of a combined 
application of ergosta-7,22-diene-3-on (20) and doxorubicin on Colo320 
cells. The final concentration of the examined components was determined 
by the previous results. At compound 20:doxorubicin 11.2:1 rate, the 
 
combination index (CI, 0.521±0.15) at the 50% growth inhibition dose 
(ED50) was indicating a synergism between the examined compounds.  
The effect of compounds 13 and 18-20 on modulation of P-gp efflux 
was evaluated by flow cytometry, measuring the rhodamine-123 
accumulation in MDR Colo320 human colon adenocarcinoma cells. 
Tariquidar, a well-known P-gp inhibitor was used as positive control. The 
FAR values were used to assess the P-gp modulating potential. Generally, 
compounds can be considered to be active when presenting FAR values 
higher than 2. Therefore the tested compounds were ineffective modulators 
on drug resistant strain Colo 320.  
Table 5. Rhodamine 123 accumulation assay results of compounds 13 and 18-20 
FSC: Forward Scatter Count - provides information about cell size 
SSC: Side Scatter Count - proportional to cell granularity or internal complexity 
FL-1: Mean fluorescence of the cells 
FAR: Fluorescence Activity Ratio 
 
Antimicrobial activity of the compounds from Fuscoporia torulosa 
Compounds 13 and 18-20 were investigated for antimicrobial activity on 
Escherichia coli, Salmonella enterica, Staphylococcus aureus and the 
methicillin and ofloxacin resistant S. aureus clinical isolate strains, however, 
none of the compounds were considered efficient. 
 
  
Samples conc. (μM) FSC SSC FL-1 FAR 
Tariquidar 0.2 1945 837 64.100 5.533 
13 20 2005 851 13.200 1.139 
18 20 2074 861 11.900 1.027 
19 20 2095 891 12.200 1.053 
20 2 2099 857 10.100 0.872 
DMSO 2.00% 2073 848 9.590 0.828 
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Hymenochaetaceae és Meripilaceae családba tartozó 
taplógombák bioaktív metabolitjainak izolálása és 
szerkezet meghatározása  
 
Bár a taplógombák a közép-európai népgyógyászat részét képezik, további 
vizsgálatok szükségesek a megfigyelt hatások igazolására, a hatóanyagok 
feltérképezésére. Munkacsoportunk fő célkitűzése volt, hogy feltérképezzük 
a hazai gombafajok pozitív élettani hatásait és a hatásért felelős anyagait. 
Előzetes vizsgálataink és az irodalom áttekintése után kutatásaim témájául 3 
fajt, az óriás bokrosgombát (Meripilus giganteus), a Porodaedalea 
chrysolomát és a vörös taplót (Fuscoporia torulosa) választottuk ki. 
Preparatív munkánknak köszönhetően a Meripilus giganteus esetében 7 
ismert és 2 új, a Porodaedalea chrysoloma feldolgozásakor 4 ismert, illetve 
1 új, a Fuscoporia torulosa mintából pedig 6 ismert és 2 új vegyületet sikerült 
izolálni. Ezen vegyületük antioxidáns hatását ORAC, illetve DPPH teszt 
segítségével eredményesen vizsgáltuk, a F. torulosából izolált ergoszta-7,22-
dién-3-on pedig szinergista hatást mutatott a doxorubicin kemoterápiás 
hatóanyaggal. 
  
 
  
 
  
 
 
